AU697814B2 - Improvements in sustainable cell line for the production of Marek's disease vaccines - Google Patents

Improvements in sustainable cell line for the production of Marek's disease vaccines

Info

Publication number
AU697814B2
AU697814B2 AU23568/97A AU2356897A AU697814B2 AU 697814 B2 AU697814 B2 AU 697814B2 AU 23568/97 A AU23568/97 A AU 23568/97A AU 2356897 A AU2356897 A AU 2356897A AU 697814 B2 AU697814 B2 AU 697814B2
Authority
AU
Australia
Prior art keywords
marek
production
cell line
disease vaccines
sustainable cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU23568/97A
Other versions
AU2356897A (en
Inventor
Amin Abujoub
Paul M Coussens
John David Reilly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/670,272 external-priority patent/US5833980A/en
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Publication of AU2356897A publication Critical patent/AU2356897A/en
Application granted granted Critical
Publication of AU697814B2 publication Critical patent/AU697814B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU23568/97A 1996-06-21 1997-05-22 Improvements in sustainable cell line for the production of Marek's disease vaccines Ceased AU697814B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/670,272 US5833980A (en) 1995-10-27 1996-06-21 Sustainable cell line for the production of the Marek's disease vaccines
US08/670272 1996-06-21

Publications (2)

Publication Number Publication Date
AU2356897A AU2356897A (en) 1998-01-08
AU697814B2 true AU697814B2 (en) 1998-10-15

Family

ID=24689728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23568/97A Ceased AU697814B2 (en) 1996-06-21 1997-05-22 Improvements in sustainable cell line for the production of Marek's disease vaccines

Country Status (8)

Country Link
JP (1) JPH104956A (en)
KR (1) KR980002250A (en)
CN (1) CN1170760A (en)
AR (1) AR007611A1 (en)
AU (1) AU697814B2 (en)
BR (1) BR9703544A (en)
ID (1) ID19429A (en)
MX (1) MX9702769A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20141482A1 (en) * 2011-11-30 2014-11-08 Merial Ltd RECOMBINANT VECTORS OF HVT EXPRESSING BIRD PATHOGEN ANTIGENS AND THEIR USES
JP2013116869A (en) * 2011-12-02 2013-06-13 Vaxxinova Kk Live vaccine against infectious bursal disease containing cell internal virus as main component
CN103977400B (en) * 2014-05-29 2015-06-17 南京创启生物科技有限公司 Method for producing marek disease live vaccine of chicken by using cell line

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
1977 J. NATL. CANCER INST. 58(2), 307-12 *
1987 ACTA MED OKAYAMA 41(3), 141-3 *
1995 VIROLOGY 214(2), 514-9 *

Also Published As

Publication number Publication date
AU2356897A (en) 1998-01-08
MX9702769A (en) 1997-12-31
BR9703544A (en) 1998-09-29
CN1170760A (en) 1998-01-21
JPH104956A (en) 1998-01-13
AR007611A1 (en) 1999-11-10
ID19429A (en) 1998-07-09
KR980002250A (en) 1998-03-30

Similar Documents

Publication Publication Date Title
AU9681498A (en) Chromophores in the preparation of novel tandem conjugates
AU5959096A (en) Human oligodendroglial progenitor cell line
SG113402A1 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
AU4426296A (en) G protein coupled receptor protein, production, and use thereof
HU9603476D0 (en) N-terminally extended proteins expressed in yeast
ZA979175B (en) Novel piperidineketocarboxylic acid derivatives their preparation and use
ZA978081B (en) 3-Substituted pyrido ¬4',3':4,5¾thieno¬2,3-d¾pyrimidine derivatives the preparation and use thereof
ZA973097B (en) Novel aspire-hydroxy acid derivatives their preparation and use
AU1819897A (en) Medicinal prophylactic "trisan"
AU8758298A (en) Process for the preparation of 2'-fluoro-5-methyl-beta -l-arabinofuranosyluridine
EP0775743A3 (en) Sustainable chick cell line infected with Marek's disease virus
AU697814B2 (en) Improvements in sustainable cell line for the production of Marek's disease vaccines
AU5240896A (en) Marek's disease vaccine
EP0770677A3 (en) Improved sustainable chicken cell line for the production of Marek's disease vaccines
HUP9701302A3 (en) Baker's yeast
GB9706130D0 (en) 2-amino-alkanoic acid derivatives,2-amino alcohols and diamines,the processses for their preparation and their uses
ZA984970B (en) Processes for preparation of Marek's disease virus using continuous mammalian cell lines.
AU4507197A (en) Idiotypic vaccine in lipid based carrier for b cell disorders
AU2689197A (en) Women's foundation garments which have cushions filled with gas for figure moulding
GB2331238B (en) Traveller's pillow
AU3821095A (en) Vaccine preparation recovered from bacteria grown in iron-rich media
AU8746598A (en) Tissue collector
AU1261599A (en) Gene originating in human fetal chondrocytes
Drucker-Brown Bulsa Sunsuelima: Folktales of the Bulsa in Northern Ghana
高競 Photochemically induced focal cochlear lesions in the guinea pig: Ⅰ. DAB staining and SEM study

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired